Vascular Biology |
From the Whitaker Cardiovascular Institute, Evans Department of Medicine (N.W., S.H., Y.-Y.Z., J.L.), and the Departments of Pharmacology (C.B.) and Pathology (A.C.), Boston University School of Medicine, Boston, Mass. N.W. is currently at the Medizinische Poliklinik Innenstadt, Ludwig-Maximilians-Universität, Munich, Germany.
Correspondence to Dr Joseph Loscalzo, Boston University School of Medicine, 715 Albany St W507, Boston, MA 02118-2394. E-mail jloscalz{at}bu.edu
Previous in vitro experiments have shown that hyperhomocysteinemia leads to oxidative inactivation of nitric oxide, in part by inhibiting the expression of cellular glutathione peroxidase (GPx-1). To elucidate the role of intracellular redox status on homocysteine-induced endothelial dysfunction and oxidant stress, heterozygous cystathionine ß-synthasedeficient (CBS-/+) and wild-type (CBS+/+) mice were treated with the cysteine donor L-2-oxothiazolidine-4-carboxylic acid (OTC). CBS-/+ mice had significantly lower GPx-1 activity compared with their CBS+/+ littermates, and OTC treatment led to a modest increase in tissue GPx-1 activity and significant increases in total thiols and in reduced glutathione levels in both CBS+/+ and CBS-/+ mice. Superfusion of the mesentery with ß-methacholine or bradykinin produced dose-dependent vasodilation of mesenteric arterioles in CBS+/+ mice and in CBS+/+ mice treated with OTC. In contrast, mesenteric arterioles from CBS-/+ mice manifested dose-dependent vasoconstriction in response to both agonists. OTC treatment of CBS-/+ mice restored normal microvascular vasodilator reactivity to ß-methacholine and bradykinin. These findings demonstrate that mild hyperhomocysteinemia leads to endothelial dysfunction in association with decreased bioavailable nitric oxide. Increasing the cellular thiol and reduced glutathione pools and increasing GPx-1 activity restores endothelial function. These findings emphasize the importance of intracellular redox balance for nitric oxide bioactivity and endothelial function.
Key Words: homocysteine endothelial function oxidant stress nitric oxide P-selectin
This article has been cited by other articles:
![]() |
S. Dayal and S. R. Lentz Murine Models of Hyperhomocysteinemia and Their Vascular Phenotypes Arterioscler. Thromb. Vasc. Biol., September 1, 2008; 28(9): 1596 - 1605. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Akahoshi, C. Kobayashi, Y. Ishizaki, T. Izumi, T. Himi, M. Suematsu, and I. Ishii Genetic background conversion ameliorates semi-lethality and permits behavioral analyses in cystathionine {beta}-synthase-deficient mice, an animal model for hyperhomocysteinemia Hum. Mol. Genet., July 1, 2008; 17(13): 1994 - 2005. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chrissobolis, S. P. Didion, D. A. Kinzenbaw, L. I. Schrader, S. Dayal, S. R. Lentz, and F. M. Faraci Glutathione Peroxidase-1 Plays a Major Role in Protecting Against Angiotensin II-Induced Vascular Dysfunction Hypertension, April 1, 2008; 51(4): 872 - 877. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. O. Zanardo, V. Brancaleone, E. Distrutti, S. Fiorucci, G. Cirino, and J. L. Wallace Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation FASEB J, October 1, 2006; 20(12): 2118 - 2120. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Handy Hyperhomocysteinemia: the protein C pathway to thrombosis Blood, October 1, 2006; 108(7): 2137 - 2138. [Full Text] [PDF] |
||||
![]() |
O. Postea, F. Krotz, A. Henger, C. Keller, and N. Weiss Stereospecific and Redox-Sensitive Increase in Monocyte Adhesion to Endothelial Cells by Homocysteine Arterioscler. Thromb. Vasc. Biol., March 1, 2006; 26(3): 508 - 513. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Weiss, N. Ide, T. Abahji, L. Nill, C. Keller, and U. Hoffmann Aged Garlic Extract Improves Homocysteine-Induced Endothelial Dysfunction in Macro- and Microcirculation J. Nutr., March 1, 2006; 136(3): 750S - 754S. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Kamath, A. K. Chauhan, J. Kisucka, V. S. Dole, J. Loscalzo, D. E. Handy, and D. D. Wagner Elevated levels of homocysteine compromise blood-brain barrier integrity in mice Blood, January 15, 2006; 107(2): 591 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Jiang, F. Yang, H. Tan, D. Liao, R. M. Bryan Jr, J. K. Randhawa, R. E. Rumbaut, W. Durante, A. I. Schafer, X. Yang, et al. Hyperhomocystinemia Impairs Endothelial Function and eNOS Activity via PKC Activation Arterioscler. Thromb. Vasc. Biol., December 1, 2005; 25(12): 2515 - 2521. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dayal and S. R Lentz ADMA and hyperhomocysteinemia Vascular Medicine, July 1, 2005; 10(1_suppl): S27 - S33. [Abstract] [PDF] |
||||
![]() |
R. Schnabel, K. J. Lackner, H. J. Rupprecht, C. Espinola-Klein, M. Torzewski, E. Lubos, C. Bickel, F. Cambien, L. Tiret, T. Munzel, et al. Glutathione Peroxidase-1 and Homocysteine for Cardiovascular Risk Prediction: Results from the AtheroGene Study J. Am. Coll. Cardiol., May 17, 2005; 45(10): 1631 - 1637. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dayal and S. R Lentz ADMA and hyperhomocysteinemia Vascular Medicine, May 1, 2005; 10(2_suppl): S27 - S33. [Abstract] [PDF] |
||||
![]() |
D. E. Handy, Y. Zhang, and J. Loscalzo Homocysteine Down-regulates Cellular Glutathione Peroxidase (GPx1) by Decreasing Translation J. Biol. Chem., April 22, 2005; 280(16): 15518 - 15525. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Powers, R. E. Gandley, D. L. Lykins, and J. M. Roberts Moderate Hyperhomocysteinemia Decreases Endothelial-Dependent Vasorelaxation in Pregnant But Not Nonpregnant Mice Hypertension, September 1, 2004; 44(3): 327 - 333. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, K.-H. Jhee, X. Hua, P. M. DiBello, D. W. Jacobsen, and W. D. Kruger Modulation of Cystathionine {beta}-Synthase Level Regulates Total Serum Homocysteine in Mice Circ. Res., May 28, 2004; 94(10): 1318 - 1324. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zhang, J. Ma, M. Xia, H. Zhu, and W. Ling Mild Hyperhomocysteinemia Induced by Feeding Rats Diets Rich in Methionine or Deficient in Folate Promotes Early Atherosclerotic Inflammatory Processes J. Nutr., April 1, 2004; 134(4): 825 - 830. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Devlin, E. Arning, T. Bottiglieri, F. M. Faraci, R. Rozen, and S. R. Lentz Effect of Mthfr genotype on diet-induced hyperhomocysteinemia and vascular function in mice Blood, April 1, 2004; 103(7): 2624 - 2629. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K.W. Au-Yeung, C. W.H. Woo, F. L. Sung, J. C.W. Yip, Y. L. Siow, and K. O Hyperhomocysteinemia Activates Nuclear Factor-{kappa}B in Endothelial Cells via Oxidative Stress Circ. Res., January 9, 2004; 94(1): 28 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wang, X. Jiang, F. Yang, J. W. Gaubatz, L. Ma, M. J. Magera, X. Yang, P. B. Berger, W. Durante, H. J. Pownall, et al. Hyperhomocysteinemia accelerates atherosclerosis in cystathionine beta -synthase and apolipoprotein E double knock-out mice with and without dietary perturbation Blood, May 15, 2003; 101(10): 3901 - 3907. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Robert, F. Vialard, E. Thiery, K. Toyama, P.-M. Sinet, N. Janel, and J. London Expression of the Cystathionine {beta} Synthase (CBS) Gene During Mouse Development and Immunolocalization in Adult Brain J. Histochem. Cytochem., March 1, 2003; 51(3): 363 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dayal, K. L. Brown, C. J. Weydert, L. W. Oberley, E. Arning, T. Bottiglieri, F. M. Faraci, and S. R. Lentz Deficiency of Glutathione Peroxidase-1 Sensitizes Hyperhomocysteinemic Mice to Endothelial Dysfunction Arterioscler. Thromb. Vasc. Biol., December 1, 2002; 22(12): 1996 - 2002. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ratnam, K. N. Maclean, R. L. Jacobs, M. E. Brosnan, J. P. Kraus, and J. T. Brosnan Hormonal Regulation of Cystathionine beta -Synthase Expression in Liver J. Biol. Chem., November 1, 2002; 277(45): 42912 - 42918. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Wang, C. W.H. Woo, F. L. Sung, Y. L. Siow, and K. O Increased Monocyte Adhesion to Aortic Endothelium in Rats With Hyperhomocysteinemia: Role of Chemokine and Adhesion Molecules Arterioscler. Thromb. Vasc. Biol., November 1, 2002; 22(11): 1777 - 1783. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Weiss, C. Keller, U. Hoffmann, and J. Loscalzo Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia Vascular Medicine, August 1, 2002; 7(3): 227 - 239. [Abstract] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |